Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|17|2|169-176

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.2, 2017-01, pp. : 169-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasticity of Pax-5–/– Pre-B I Cells

By  

Cells Tissues Organs, Vol. 171, Iss. 1, 2002-05 ,pp. : 38-43

Karger

Access to resources Recommend Favorite

WT1 and Pax2 Re-Expression Is Required for Epithelial-Mesenchymal Transition in 5/6 Nephrectomized Rats and Cultured Kidney Tubular Epithelial Cells

By  

Cells Tissues Organs, Vol. 195, Iss. 4, 2011-07 ,pp. : 296-312

Karger

Access to resources Recommend Favorite

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

By Oh Eun-Taex  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Histone Acetyltransferase GCN5 and Histone Deacetylase 1 in the Cultured Mouse Preimplantation Embryos

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1772-1777

Bentham Science Publishers

Access to resources Recommend Favorite

Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species

By  

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-04 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite